Loading...
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
Coombes, R Kilburn, L Snowdon, C Paridaens, R Coleman, R Jones, S Jassem, J Van de Velde, C Delozier, T Alvarez, I
Coombes, R
Kilburn, L
Snowdon, C
Paridaens, R
Coleman, R
Jones, S
Jassem, J
Van de Velde, C
Delozier, T
Alvarez, I
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2007
Publisher
Collections
Keywords
Breast Cancer
Oestrogen Receptors
Tamoxifen
Oestrogen Receptors
Tamoxifen
Type
Article
Citation
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial 2007, 369 (9561):559 The Lancet